Jhoots Pharmacy Portfolio Rescued by Allied Pharmacies

Key Takeaways

• Mass Acquisition: Allied Pharmacies has acquired a total of 129 Jhoots Pharmacy branches through a series of pre-pack deals, including a final tranche of 68 sites in early January 2026.
• Staff Arrears: In a rare move for distressed acquisitions, Allied has pledged to settle outstanding salary arrears for Jhoots employees "in full" to rebuild trust within the workforce.
• Financial Collapse: The insolvency follows a £5.02 million pre-tax loss reported for the 2023 financial year, exacerbated by £1.7 million in bank debt and nearly £925,000 in unpaid locum fees.

The Story of Jhoots' Collapse

The financial distress seen by Jhoots underscores a decade of "systemic underfunding" in the UK pharmacy sector, coupled with rising operational costs and National Insurance hikes. Post the period of turbulence, it was confirmed that Allied Pharmacies had secured 68 additional sites via an accelerated sale process managed by administrators from FRP Advisory. This was confirmed on 6th January.

This follows an initial acquisition of 61 branches in November 2025, effectively moving the vast majority of the 151-strong Jhoots estate under new management after months of operational chaos that saw staff walkouts and branches delisted by the NHS.

Factors leading up to the Administration

The downfall of Jhoots was marked by a rapid deterioration in liquidity and governance. Despite doubling turnover to £21.4 million in 2023 through aggressive acquisitions, the group swung from a £1.8 million profit to a £5.02 million loss.

The operational reality was even more stark:

• Staffing Crisis: In Abingdon, staff famously shut the shop in August 2024 after being left without a manager for 10 weeks.
• Regulatory Intervention: The General Pharmaceutical Council (GPhC) and NHS Integrated Care Boards (ICBs) issued nearly 1,300 remedial and breach notices due to "unacceptable" service levels.
• Debt Structure: Lloyds Bank held 16 unsatisfied charges against the business, while the Pharmacists' Defence Association (PDA) reported nearly £1 million in unpaid locum fees.

Are there any other challenges the UK pharmacy market is grappling with?

The industry is currently grappling with a "funding gap." While the government announced a 30% increase in the Community Pharmacy Contractual Framework (CPCF) budget for 2025/26, operators are facing:

• Increased National Insurance (NICs): Rising from 13.8% to 15% on employee earnings.
• Margin Pressures: High drug procurement costs versus fixed NHS reimbursement rates.
• The "Boots/Lloyds Effect": Major players have divested hundreds of sites, creating a "buyer's market" for regional multiples like Allied to scale up.

Next Steps for Stakeholders after Administration

For the 35+ staff already paid and the hundreds more awaiting arrears, the focus shifts to operational stability. However, for locum pharmacists and unsecured creditors, the recovery outlook remains tied to the liquidation of the remaining Jhoots entities. Administrators from FRP Advisory will continue to realize any residual non-core assets to maximize returns.

Learn more about the financial distress overshadowing the pharmacy market in the UK.

FAQ: Strategic Insights for Distressed Buyers

What made Jhoots an attractive target despite its losses?
The "value" was in the NHS Pharmacy Contracts and the geographical footprint. In the UK, opening a new pharmacy is heavily restricted by "market entry" rules. Acquiring an existing contract via administration is often the only way to expand into specific high-traffic regions.

How did Allied Pharmacies manage the "reputational risk"?
By proactively announcing the payment of staff arrears and engaging with the GPhC, Allied decoupled the brand’s physical assets from the "toxic" management reputation of the previous owners.

Is there more M&A expected in the community pharmacy sector?
Yes. Experts predict a strong current of consolidation through 2026. Smaller independent chains that cannot weather the current National Insurance hikes and locum cost volatility are prime targets for larger, more efficient groups.

How can I find similar healthcare and retail assets?
Follow our Healthcare hub for daily updates on winding-up petitions and administration appointments across the UK.